Strategies to Enhance Recruitment of Female Participants to Cardiovascular Research
This consensus document outlines strategies to increase female representation in cardiovascular clinical trials, addressing significant under-representation of women.
- Publisher
- British Cardiovascular Society in collaboration with the British Heart Foundation Clinical Research Collaborative
- Published
- Length
- 14 pages
- File
- 2.8 MB PDF
Quick answer
Strategies to Enhance Recruitment of Female Participants to Cardiovascular Research is a 14-page whitepaper from British Cardiovascular Society in collaboration with the British Heart Foundation Clinical Research Collaborative covering GLOBAL pharma intelligence. This consensus document outlines strategies to increase female representation in cardiovascular clinical trials, addressing significant under-representation of women.
Research library Data sources More from British Cardiovascular Society in collaboration with the British Heart Foundation Clinical Research Collaborative
Why this matters
This consensus document outlines strategies to increase female representation in cardiovascular clinical trials, addressing significant under-representation of women.
Executive summary
- This consensus document outlines strategies to increase female representation in cardiovascular clinical trials, addressing significant under-representation of women.
Market Impact
| Regulatory | high |
|---|---|
| Commercial | high |
| Competitive | medium |
| Investment | high |
Who should read this
- Regulatory professionals
- Clinical operations
- BD & strategy teams
Ask about this report
AI-assisted answers grounded in NovaPharmaNews intelligence
Answers use retrieved site intelligence plus AI synthesis. Verify critical decisions with primary sources.
Download the full 14-page PDF
Free · 2.8 MB · Instant access after email
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality among females, yet they represent only 25-30% of clinical trial participants. This document highlights the urgent need for:
Frequently asked questions
What whitepapers does NovaPharmaNews publish?
Our research library curates FDA, EMA, and industry publisher PDFs — regulatory guidance, clinical analyses, manufacturing reports, and market intelligence. Each report includes an AI-summarized landing page with key takeaways and a gated PDF download.
How do I download a whitepaper?
Open any report page, scroll to the download form, and enter your work email. You receive instant PDF access and can opt in to weekly pharma intelligence updates. Downloads are free for healthcare professionals.
How do whitepapers connect to news and pipeline data?
Report pages link to related intelligence — company profiles, drug INN pages, clinical trials, pipeline programs, and topic hubs. Use the intelligence spokes on each page to explore the entity graph behind the research.
Ready to read the full report?
Join 12,000+ pharma leaders getting deep industry analysis delivered weekly.
Related topic hubs
Editorial coverage and intelligence directories for this report's beat.
Explore the intelligence platform
Related intelligence
British Society of Gastroenterology Guidelines on Inflammatory Bowel Disease in Adults: 2025
The updated BSG guidelines emphasize the necessity of ileocolonoscopy for IBD diagnosis and advocate for immunomodulators in all patients.
🔒 Ensuring Compatibility for GLP-1-based Drugs
The rise of GLP-1 agonists like Semaglutide demands innovative ready-to-use cartridges to enhance delivery efficiency and reduce costs in ob…
🔒 From Automotive to MedTech: Proven Software Development Practices
This whitepaper outlines how MedTech can leverage automotive software development practices to enhance compliance and accelerate innovation …